Rafina Innovations Inc (VICA)

[badbadbad]

VICA - My PROFIT FRIDAY Play!

VICA - $2 as a 52-Week HIGH we could be in for 614% in GAINS!


Greetings Traders,

VICA’s technology Flexisense™ in many opinions is the next generation of sensing technologies for wearable devices.

VICA’s targeted partners and customers are highly innovative manufactures within different industries, that focus on gaining competitive advantages through enhancing their product propositions with new technologies.

VICA works on a licensing business model aiming to incorporate Flexisense in different products.

Increasing prevalence of chronic diseases such as heart failure, obesity, diabetes and hypertension are boosting the demand for technologically advanced medical devices.

Nearly $6 trillion will be spent on IoT solutions over the next five years with another estimate placing the overall IoT combined with M2M industry at 4.3 trillion by 2024.

A segmented Healthcare market forecast may reach $410 billion by 2022.

Hospitals and Clinics segment dominated the overall Internet of Things in Healthcare Market in terms of revenue share with over 32% in 2015.

The IoT Healthcare Market suggests insane growth in a 5-year forecast when it was suggested it would go from $32 Billion USD to $163 Billion by 2020.

The implications of which set an unprecedented growth pattern.

One of the companies in that segment is VICA, a start-up licensing technology in the healthcare, medical and appliance industry.

More specifically in the IoT “Internet of Things” industry that creates hardware solutions aiming to empower the user with on demand information, aiming to enhance living quality.

VICA’s Technologies division was the winner of a Startup Grant for the technology fair at the 10th International Conference on Advanced Technologies & Treatments for Diabetes.

VICA’s potential appears in evaluating optimal entry points for short term profits. At the time of writing the article, barchart.com short term indicators for VICA suggest bullish short term patterns:

TrendSpotter indicating: BUY
7 Day Average Directional Indicator: BUY
10 – 8 Day Moving Average Hilo Channel: BUY
20 day Moving Average vs Price: BUY
20 Day Bollinger Bands: BUY
VICA has a R&D center in Glasgow, Scotland and working on disruptive technologies in the fields of Digital Health, Prosthetics, Orthotics, Diabetes, Assistive Devices and Sports and Wellbeing.

The company produced a video for vimeo introducing the concepts that most likely lead to discussions with New Balance Athletics, Inc. and discussions with Tharawat of the Kingdom of Saudi Arabia to examine market potential collaboration in prosthetics and orthotics as well as diabetic foot clinics.

It is a unique sensors based technology, a cost effective solution to a wide range of IoT projects that can be incorporated into a big variety of products.

Flexisense™ measures pressure and, uniquely, shear forces and provides on demand information wirelessly.

BUSINESS SUMMARY

(VICA – HCi Viocare)

http://www.hciviocare.com/

http://flexisense.hciviocare.com/health/

https://hci-viocare.co.uk/

HCi Viocare or VICA has two fully owned subsidiaries, (1) HCi Viocare Technologies and (2) HCi Viocare Clinics.

HCi Viocare Technologies engages in developing hardware solutions aiming to empower the user by providing on demand information and enhancing living quality.

The R&D center located in Glasgow, Scotland, is working on a large portfolio of cutting edge, revolutionary and disruptive technologies in the fields of Digital Health, Prosthetics, Orthotics, Diabetes, Assistive Devices and Sports & Wellbeing. The Company has developed a unique sensing technology with the brand name Flexisense™, which uses a multitude of micro sensors to detect pressure as well as shear that is unique over other sensing technologies. The sensors are wirelessly connected to smart devices providing real time and on demand information. HCi Viocare Technologies works on a licensing business model.

HCi Viocare Clinics: creating the first cross-border independent chain of Prosthetics & Orthotics (P&O) and Diabetic Foot clinics in Europe and the Middle East.

MARKET OUTLOOK

The IoT “Internet of Things” industry that creates hardware solutions aiming to empower the user with on demand information, aiming to enhance living quality.

For the entire IoT “Internet of Things” industry forecasts suggest 34 billion devices connected to the internet by 2020, up from 10 billion in 2015. IoT devices will account for 24 billion devices, while traditional computing devices (e.g. smartphones, tablets, smartwatches, etc.) will comprise 10 billion devices.

Nearly $6 trillion will be spent on IoT solutions over the next five years with another estimate placing the overall IoT combined with M2M industry at 4.3 trillion by 2024.

Research Nester suggests the Global Internet of Things (IoT) market reached USD 598.2 Billion in 2015 and the market is expected to reach USD 724.2 Billion by 2023.

Further, the market is projected to register a CAGR of 13.2% during the forecast period 2016-2023 globally.

IDC a premier global marketing company, predicted IoT spending would reach $1.29 trillion with a compound annual growth rate of 15.6 percent by 2019.

Businesses will be the top adopter of IoT solutions, improving bottom lines by 1) lowering operating costs; 2) increasing productivity; and 3) expanding to new markets or developing new product offerings.

Forecasts suggests the government will be the second-largest adopters of IoT ecosystems focused on increasing productivity, decreasing costs, and improving their citizens’ quality of life.

Consumers will lag behind businesses and governments in IoT adoption.

The IoT Healthcare Market suggests insane growth in a 5-year forecast when it was suggested it would go from $32 Billion USD in 2015 to $163 Billion by 2020.

A more recent forecast expects the IoT Healthcare market to reach $410 billion by 2022.

Hospitals and Clinics segment dominated the overall Internet of Things in Healthcare Market in terms of revenue share with over 32% in 2015.

Increasing prevalence of chronic diseases such as heart failure, obesity, diabetes and hypertension are boosting the demand for technologically advanced medical devices.

The new generation connected medical devices enable real-time patient monitoring and help the medical professionals to swiftly respond to the patient needs.

For instance, the vital sign monitors, activity monitors, safety monitors and medication monitors are routinely used for patent monitoring and medication management.

Business Insider's premium research service, forecasts that the installed base of healthcare IoT devices (not including wearable devices such as fitness trackers) will grow from approximately 95 million in 2015 to 646 million in 2020.

According to the data published by the U.S. based Family Caregiver Alliance (FCA) in 2015, nearly 63% of the population availing long term healthcare services are people aged above 65 years.

This population is expected to drive the demand for technology enabled healthcare services.

The growing geriatric population, and the high unmet medical needs for home healthcare and long term healthcare services are driving the growth of telemedicine and remote patient monitoring and these factors are expected to positively reinforce the IoT in Healthcare market over the forecast period.

The introduction of technologically advanced connected medical devices, penetration of smart phones, and use of software automation, to enable faster patient testing, and provide better accuracy, ease of usage, and portability are expected to serve the Internet of Things in healthcare market as high-impact rendering drivers over the forecast period.

The introduction of technologically advanced connected medical devices, penetration of smart phones, and use of software automation, to enable faster patient testing, and provide better accuracy, ease of usage, and portability are expected to serve the Internet of Things in healthcare market as high-impact rendering drivers over the forecast period.

The healthcare practitioners are increasingly using technology platforms to serve the growing hospital and patient needs. Moreover, various routine activities such as patient data recording, data storage and data analysis have been streamlined using software’s and cloud storage systems, leading to significant reduction in healthcare operational costs and errors.

The growth of big data analytics, cloud services and artificial intelligence for healthcare applications is gaining significant traction. Several leading technology firms are investing huge resources to tap the potential of the IoT in healthcare market. For instance, IBM has developed the Watson platform for oncology, drug discovery, and clinical trial matching. This platform has combined the power of supercomputing with the huge amount of healthcare research and patient data.

Further more, the use of RFID tags for medication management, asset tracking and asset transportation and development of novel products such as smart pills and smart beds are expected to boost the IoT in Healthcare market over the forecast period.



Make sure you are ready to get all my alerts FAST by texting the word "ProTrader" to "99000" (regular text messaging rates may apply)

Also PLEASE take the time to read the following AGAIN:

( I DO NOT MAKE ANY RECOMMENDATIONS TO BUY OR SELL ANY STOCKS, I JUST PROFILE COMPANIES AND YOU DECIDE WHAT TO DO)

Placing a Trade

First and foremost, you should always have streaming Level II quotes when trading. I honestly do not know how anyone trades without it! When trading, please follow the below guidelines:

Always use a Limit Order:

Most brokers won’t even allow you to use Market Orders. Limit Orders allow you to set the price that you want to buy and sell the stock at. This is common knowledge however, you may see some novice traders make the mistake of placing a market order to sell and take out all buyers at the bid, effectively overselling the stock to lower prices.

Buy and Sell at the Ask:

Many don’t realize that when you buy at the Ask price, you are HELPING the stock price to move up! Once that offer is gone from the shares you purchased, Market Makers could move up to the next offer price as they will see there are buyers at the current price. If you decide to place an order at the bid, you are basically hoping someone will sell their shares to you at this price and you may never get filled and miss the action. It is not always a bad idea to bid sit, as you are creating “bid support”, if you believe the price may come down again and you are not willing to buy higher.

Using Stop Limit Orders:

Some brokers do not allow you to use stops, however, if you can – it is always a good idea to set your stop loss at the lowest price you are willing to take a loss. You may kick yourself when the stock moves back up and your stop already executed, but remember, there will always be other opportunities and its always best to cut your losses just in case.

All or None Orders (Fill or Kill):

An example of an all or none order is when someone places an order to buy 100,000 shares @ .01 as an “all or none limit” order. By doing this they are telling the market that they wish to be filled on their entire position at .01 or not to be filled at all. For some reason we have seen market makers ignore these sort of orders on many occasions especially when a stock is on the move. We suggest against it but you will ultimately make the decision.

Do Not Chase (ONE OF THE MOST IMPORTANT):

Many people want to buy a stock so badly that they end up chasing the stock as it goes up. When they finally fill their order, they may have purchased it too high as traders who bought shares earlier begin to take profit, effectively lowering the stock price and making you a bag holder. Remember, 90% of the time, a stock will always retrace/dip back to an attractive level for you to grab shares.

Stock Gaps:

If a stock gaps up too high in pre-market, do Not Chase It. A big gap is typically 20-50% or more pre- market or within the first 5-10 minutes of the market opening. Most stocks that gap up will come down again during the day depending on what created the catalyst. Buying is always the catalyst but every once in a while there is earthshattering news on some of these small caps that makes pullbacks unlikely in the short term. Most of the time, when a stock gaps up the market makers will attempt to push it lower starting at this time to try to get investors to panic and sell shares back to them so they can make a profit on any shares they are short from filling orders on the gap. If you like the stock and it gaps up you can usually pick up cheaper shares when and if the market settles back.

Sell Into Strength Not Weakness:

Once you have taken a position in a stock you need to decide the price you would like to sell your shares. Most would recommend that you put a GTC sell order at that price. Unfortunately as traders have learned to utilize level 2, its best not to do submit GTC sell orders due to the possibility that your order will be represented by a market maker and it will seem as if there is resistance at that level which may compel sellers to get out of their position at a price lower than your price. We suggest that you watch the stock closely and once it hits your price target you can submit your order to sell. It’s important to understand that it’s always best to liquidate the stock into strength and preferably in smaller increments if you have a big position.

There you have it!! These are ALL my biased, amateur and unlicensed opinions, should YOU choose freely, knowingly and intelligently to Play ANY of my featured play's!!

(Please READ my statement below as well, it will help you understand how I benefit from this newsletter)

Also always remember that every single alert I send is very volatile and risky. Any one of them could turn into a big loser. In my personal opinion, no matter how much potential any company has, 99% of the time all that matters is HOW THE STOCK TRADES. If a stock doesn’t trade well, nothing else matters. Don’t believe the hype. Be sure to use a tight stop, book profits quickly on these volatile trades, never let any one trade move too far against you, watch out for gaps, make sure the stock is trading in a healthy way before you enter, and monitor it closely to make sure momentum is positive. It’s always safest to book profits quickly, even on alerts with long-term potential. (Amateur biased unlicensed opinions)

I would like to also explain how my Newsletter Makes MONEY!!

I DON’T FRONTLOAD, BUY, RECEIVE any SHARES of a Company I Profile!! I NEVER OWN ANY POSITION IN A COMPANY I ALERT/PROFILE!! It would be UNFAIR, WRONG and ILLEGAL for me to have a position in ANY Company I ever Profile on my Newsletter! I am what is known as a STOCK PROMOTER!!

I just wanted to address this issue for some people who might think I trade the companies I profile on my Newsletter or I own a position before or during the time I profile them!!! The honest truth is I DO NOT!!….. I do get CASH compensation to profile companies most of the times I talk about them in my Newsletter, this is HOW I MAKE MONEY and pretty much how 99% of ALL the other Newsletters out there make money…… Most of you have signed up to my Newsletter because of an advertisement you saw, well it costs money to run those advertisements…. I ALWAYS Disclose how much and who paid me in my Disclaimer at the end of each e-mail!!!

Here is some information directly from the SEC Website: http://www.sec.gov/investor/pubs/cyberfraud/newsletter.htm

Tips for Checking Out Newsletters

“Find out whether the newsletter received payment to “tout” or recommend the stock and, if so, what it received and from whom.

Because the U.S. Constitution’s First Amendment protects freedom of speech, the SEC cannot simply prohibit newsletters from recommending or touting particular stocks. But when newsletters receive payment for touting, the securities laws require them to disclose specifically who paid them, the amount, and the type of payment (cash, stock, or some other thing of value).

Read carefully what the newsletter says about payments it receives.

Be suspicious of newsletters that do not specifically disclose these items: who paid them, the amount, and the type of payment. The following examples raise red flags because they do not contain specific information:

“From time to time, XYZ Newsletter may receive compensation from companies we write about.”

“From time to time, XYZ Newsletter or its officers, directors, or staff may hold stock in some of the companies we write about.”

“XYZ Newsletter receives fees from the companies we write about in our newsletter.”

Think twice about newsletters that bury their disclosures or put them in tiny, hard-to-read typeface. Legitimate online newsletters that have been paid to tout stocks will clearly and specifically tell investors who paid them, the amount, and the type of payment. Look for their disclosure statements in articles about particular companies or in a list or chart on their websites.”

I hope this answers a lot of your questions and also gives you a better perspective to my play’s the Next Time you see one!! Don’t forget to tell everyone you know about PTE.la and help my Newsletter Grow!!

Remember to trade smart, research your options, and use due diligence!

Sincerely,

PTE.la

© 2016 PTE.la PTE, LLC (publisher of PTE.la) is NOT registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for PTE, LLC may have long or short positions in securities that may be discussed on this website or newsletter. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are simulated figures from virtual simulated portfolios.

We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. PTE.la’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as arecommendation by PTE.la or an offer or solicitation to buy or sell any security. Neither the owner of PTE.la nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with alicensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. To review our complete disclaimer and additional information, please visit http://www.PTE.la. PTE.la makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.

PTE.la is owned and operated by PTE LLC. PTE LLC has been compensated up to Thirty-Five Thousand Dollars Cash via bank wire transfer by a third party (World Wide Media Group) for a 1 Day Marketing Program regarding VICA. Any compensation received by PTE LLC constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. A third party of PTE LLC may have shares and may liquidate, which may negatively affect the stock price. PTE LLC affiliates may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the market.

Some of the content in this release contains forward - looking information within the meaning of Section 27 A of the Securities Act of 1 9 9 3 and Section 21 E of the Securities Exchange Act of 1 9 3 4 including statements regarding expected continual growth of the profiled company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any forward - looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company’s filings with the Securities and Exchange Commission. However, acompany’s past performance does not guarantee future results.

Generally, the information regarding a company profiled is provided from public sources which we believe to be reliable but is not guaranteed by us as being accurate. Further specific financial information, filings and disclosures as well as general investor information about the profiled company, advice to investors and other investor resources are available at the Securities and Exchange Commission (“SEC”) website www.sec.gov and the Financial Industry Regulatory Authority (“FINRA”) website at www.finra.org. Any investment should be made only after consulting with a qualified investment advisor and reviewing the publicly available financial statement and other information about the company profiled and verifying that the investment is appropriate and suitable. PTE.la makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained in this release or on our website.

Disclaimer



If you no longer wish to receive our emails, click the link below:
Unsubscribe

Pro Trader Elite 146 Ferry St Newark, New Jersey 07105 United States